SURGICAL TREATMENT OF BREAST CANCER

DATA FROM A RENOWNED INSTITUTION IN THE BRAZILIAN NORTHEAST

Authors

  • Cibele Vasconcelos de Oliveira Instituto do Câncer do Ceará
  • Francisco Pimentel Cavalcante Instituto do Câncer do Ceará
  • Rafael Valente Batista Universidade Estadual do Ceará
  • José Carlos Lucena de Aguiar Ferreira Universidade Estadual do Ceará
  • Olívio Feitosa Costa Neto Universidade Estadual do Ceará
  • Marcos Venício Alves Lima Universidade Estadual do Ceará. Instituto do Câncer do Ceará

Keywords:

Sentinel lymph node biopsy, carcinoma, ductal, breast, breast neoplasms

Abstract

Introduction: Worldwide, breast cancer is the neoplasia that most affects women, after skin cancer, and accounts for 25% of new cases each year. Over the past 40 years, the survival rate has been increasing in developed countries — currently, it is 85% in 5 years —, while in developing countries it remains between 50 and 60%. As such, routine use of mammography throughout the world is considerably important. Objectives: To describe demographic and pathological characteristics in addition to the surgical approach of patients with invasive breast carcinoma in a renowned institution. Methods: A cross-sectional, descriptive study using secondary data obtained from medical records of breast cancer patients operated on at the Cancer Institute of Ceará (ICC), from 2002 to 2012. Data were analyzed using Epi Info 7.0 software. Results: The study population included 746 patients with primary breast tumors, of which 626 (84%) were invasive. Within the invasive breast tumors, the majority (554 – 88.49%) were of the invasive ductal carcinoma (IDC) type. Concerning stages, 351 cases (56.07%) were stage II. The average age of patients was 41 to 50 years old, and T2 tumors measured approximately 2 to 5 cm. The most frequent surgery was a quadrantectomy. A sentinel lymph node biopsy (SNB) was performed in 368 patients (58.78%). Conclusion: O ur c asuistry p rovides i mportant i nformation w ith r egard t o t he p rofile o f p atients s urgically t reated a t a renowned public institution in the Brazilian Northeast. Diagnosing the disease at an advanced stage still occurs at this institution, which results in high rates of mastectomy. Thus, better results tend to be obtained as better screening proposals are provided.

Downloads

Download data is not yet available.

References

Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Instituto Nacional de Câncer José Alencar Gomes da Silva. Coordenação de Prevenção e Vigilância de Câncer. Estimativa 2016: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2015.

Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000 May 20;355(9217):1822.

Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control. 2004 Jul-Aug;11(4):222-30.

Nyström L, Bjurstam N, Jonsson H, Zackrisson S, Frisell J. Reduced breast cancer mortality after 20 + years of followup in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg. J Med Screen. 2017 Mar;24(1):34-42.

Gebrim LH, Quadros LGA. Rastreamento do câncer de mama no Brasil. Rev Bras Ginecol Obstet. 2006 June;28(6):319-23.

Fisher B, Montague E, Redmond C, Deutsch M, Brown GR, Zauber A, et al. Findings from NSABP Protocol No. B-04-comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome. Cancer. 1980 Jul 1;46(1):1-13.

Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of followup in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995 Nov 30;333(22):1456-61.

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010 Oct;11(10):927-33.

Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, et al. Surgical complications associatedwith sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006 Apr;13(4):491-500.

Morrow M, Harris JR, Schnitt SJ. Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better. N Engl J Med. 2012 Jul 5;367(1):79-82.

Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011 Feb 9;305(6):569-75.

Freitas-Junior R, Siqueira LB, Carrijo ENA, Lacerda RP, Paulinelli RR, Rahal RMS, et al. Variação temporal do tratamento cirúrgico do câncer de mama em um hospital universitário na região Centro-Oeste do Brasil. Rev Col Bras Cir. 2013 June;40(3).

Haddad CF. Características clínico-patológicas e estadiamento ao diagnóstico de pacientes com câncer de mama em um centro de saúde do interior de Minas Gerais. Rev Bras Mastol. 2014;24(4):103-8.

Nunes BA, Siqueira SL, Pereira SM, Pacheco TJ, Pessanha TO, Mendonça SB. Perfil epidemiológico dos pacientes diagnosticados com câncer de mama em Campo dos Goytacazes. Rev Bras Mastol. 2012;22(4):117-23.

Cintra JRD, Guerra MR, Teixeira MTB. Sobrevida específica de pacientes com câncer de mama não-metastático submetidas à quimioterapia adjuvante. Rev Assoc Med Bras. 2008;54(4):339‑46.

Abreu E, Koifman S. Fatores prognósticos no câncer da mama feminina. Rev Bras Cancerol. 2002;48:113-32.

Macchetti AH. Estadiamento do câncer de mama diagnosticado no sistema público de saúde de São Carlos. Medicina (Ribeirão Preto). 2007;40(3):394-402.

Piato JR, Carvalho FM, Costa PA, Barros ACSD. Biopsia do linfonodo sentinela. In: Barros ACSD, Buzaid AC. Câncer de mama: tratamento multidisciplinar. São Paulo: Dendrix; 2007. p.98-121

Downloads

Published

2017-10-07

How to Cite

Oliveira, C. V. de, Cavalcante, F. P., Batista, R. V., Ferreira, J. C. L. de A., Costa Neto, O. F., & Lima, M. V. A. (2017). SURGICAL TREATMENT OF BREAST CANCER: DATA FROM A RENOWNED INSTITUTION IN THE BRAZILIAN NORTHEAST. Mastology, 27(4), 320–323. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/522

Issue

Section

Original Articles